This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of +400.00% and +21.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in PACS Group, Inc. (PACS): Can Its 21.8% Jump Turn into More Strength?
by Zacks Equity Research
PACS Group, Inc. (PACS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
HealthEquity (HQY) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
HealthEquity (HQY) delivered earnings and revenue surprises of 19.75% and 3.03%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Mesa Labs (MLAB) delivered earnings and revenue surprises of -18.91% and 1.53%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Auna S.A. (AUNA) Q1 Earnings Top Estimates
by Zacks Equity Research
Auna S.A. (AUNA) delivered earnings and revenue surprises of 90% and 5.95%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Doximity (DOCS) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Doximity (DOCS) delivered earnings and revenue surprises of 40.74% and 3.39%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Establishment Labs (ESTA) delivered earnings and revenue surprises of 15.66% and 0.06%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Premier, Inc. (PINC) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Premier (PINC) delivered earnings and revenue surprises of 41.94% and 9.42%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
PACS or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PACS vs. HQY: Which Stock Is the Better Value Option?
Lighting Up the Christmas Tree With Top-Ranked Stocks for 2025
by Sweta Killa
We have crafted a tree with the top-ranked stocks that have the potential to outperform in 2025.
PACS vs. MEDP: Which Stock Is the Better Value Option?
by Zacks Equity Research
PACS vs. MEDP: Which Stock Is the Better Value Option?
PACS Group Crashes after Hindenburg Report
by David Bartosiak
Skilled nursing provider PACS is under pressure after Hindenburg Research's scathing piece.
LTH vs. PACS: Which Stock Is the Better Value Option?
by Zacks Equity Research
LTH vs. PACS: Which Stock Is the Better Value Option?
LTH vs. PACS: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LTH vs. PACS: Which Stock Is the Better Value Option?
LTH or PACS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LTH vs. PACS: Which Stock Is the Better Value Option?